Myelodysplastic syndromes (MDS) often go unnoticed when only a complete blood count is performed on the patient. Sysmex X-Class analysers can measure the granularity of leukocytes which is often reduced in MDS. NEUT-X, the measure of neutrophil granularity, is an excellent tool to filter samples suspected of MDS in anaemic patients.
By combining the WDF and WPC channels both the sensitivity and specificity for detecting reactive and malignant cells is optimised. The measurement technology of XN-Series analysers detects the white blood cell functionality and the novel ‘Extended Inflammation Parameters’ let you quantify activated lymphocytes and neutrophils, and the results can be applied once a malignancy has been excluded.
Determining the aetiology of thrombocytopenia is of major importance. The immature platelet fraction (IPF) can help you promptly differentiate between ineffective bone marrow production and increased destruction or consumption of platelets. Find out more about the use of this parameter here.
The treatment of immune thrombocytopenia (ITP) can be challenging. The immature platelet count (IPF#) can help, making it easier to monitor the efficacy of the different treatment mechanisms and assessing bleeding risks. This white paper explains how.